Edition:
United States

ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

32.62USD
4:00pm EDT
Change (% chg)

$-0.24 (-0.73%)
Prev Close
$32.86
Open
$32.86
Day's High
$32.98
Day's Low
$32.16
Volume
436,813
Avg. Vol
707,330
52-wk High
$43.89
52-wk Low
$16.65

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.54 December 29 Aug 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 2
(2) OUTPERFORM 6 7 7 7
(3) HOLD 2 1 2 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.11 2.00 2.10 1.90

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 7 2.90 7.04 0.74 13.61
Quarter Ending Dec-16 7 9.45 14.21 1.72 18.15
Year Ending Dec-16 7 12.43 18.21 2.56 65.97
Year Ending Dec-17 7 73.88 148.85 20.25 215.76
Earnings (per share)
Quarter Ending Sep-16 8 -0.54 -0.38 -0.64 -0.36
Quarter Ending Dec-16 8 -0.51 -0.34 -0.62 -0.34
Year Ending Dec-16 8 -2.11 -1.81 -2.34 -1.18
Year Ending Dec-17 8 -1.70 -0.94 -2.37 -0.17
LT Growth Rate (%) 1 9.50 9.50 9.50 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-16 0.09 0.10 0.01 5.78
Quarter Ending Mar-16 0.15 0.00 0.15 97.32
Quarter Ending Dec-15 0.06 0.02 0.04 69.70
Quarter Ending Sep-15 0.06 0.04 0.02 30.48
Quarter Ending Jun-15 0.06 0.00 0.06 98.30

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-16 2.90 2.90 3.91 4.10 13.61
Quarter Ending Dec-16 9.45 9.45 13.89 13.95 18.15
Year Ending Dec-16 12.43 12.43 17.91 18.15 65.97
Year Ending Dec-17 73.88 73.88 77.88 85.51 215.76

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-16 0 0 2 3
Quarter Ending Dec-16 0 0 1 3
Year Ending Dec-16 0 0 1 2
Year Ending Dec-17 0 0 0 3
Earnings

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$127.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.